e-ISSN: 2394-2967
logo

British Journal of Medical and Health Research

LoginTrack

📢 Latest Update: Call for Papers: Special Issue on Medical and Health Research – Submit to British Journal (BJMHR) by March 31, 2026

📢 Latest Update: Call for Papers: Special Issue on Medical and Health Research – Submit to British Journal (BJMHR) by March 31, 2026

Volume 5, Issue 8 - 2018 (August 2018 Issue 8)

Volume 5 Issue 8 Cover

Issue Details:

Volume 5 Issue 8
Published:Invalid Date

Editorial: August 2018 Issue 8

Welcome to the 2018 issue of British Journal of Medical and Health Research. This issue showcases the remarkable breadth and depth of contemporary research across multiple disciplines. From cutting-edge applications of machine learning in climate science to the revolutionary potential of quantum computing in drug discovery, our featured articles demonstrate the power of interdisciplinary collaboration in addressing global challenges.

We are particularly excited to present research that bridges traditional academic boundaries, reflecting our journal's commitment to fostering innovation through cross-disciplinary dialogue. The integration of artificial intelligence with environmental science, the application of blockchain technology to supply chain management, and the convergence of urban planning with smart city technologies exemplify the transformative potential of collaborative research.

As we continue to navigate an era of rapid technological advancement and global challenges, the research presented in this issue offers both insights and solutions that will shape our future. We thank our authors, reviewers, and editorial board members for their continued dedication to advancing knowledge and promoting scientific excellence.

Dr Hemangi J Patel
Editor-in-Chief
British Journal of Medical and Health Research

Articles in This Issue

Showing 3 of 3 articles
Research PaperID: BJMHR0508001

Antimicrobial Activity of Aspergillus Gliotoxin on S.aureus in Diabetic's Patient's Type-2

Burooj M. Razooqi Al-aajem, Adawia F. Abaas, Anaam . F, Eptissam Y. Pirko

Diabetes mellitus is a serious public health problem, S. aureus is the most common bacteria isolated from ulceration of diabetic patients, and increase the risk of S. aureus carriage in patients with diabetes may reflect association between diabetes and bacterial carriers. The aim of the study was to estimation rate of S. aureus carrier in diabetic's patients type-2 and determine antimicrobial effect of Gliotoxin on previous bacterial carriage in type-2 diabetes. The study was conducted on 450 diabetics' patients, attended the out patients clinic in Baquba Teaching Hospital, their ages ranged from15-65years, with mean age of 36.15, who were randomly selected, during the period from May 2016 to April 2017, patients were classified into two groups according to type of diabetes, group1 included: 184 with type1-diabetes, and group2 included 266 with type2-diabetes, 97 patients with foot ulcers. Swabs were taken from anterior nares, toe and axillae for each diabetic patient type-2, identified based on standard bacteriological methods. Using Kirby-Bauer method for detection antibacterial effect of Gliotoxin. The results showed rates of bacterial carriage in anterior nares of type-2diabetic patients without complications were (11.4%), (4.4%), respectively for S. aureus and MRSA, in type-2 diabetes with complications were (8.6%),(2.1%) respectively for S. aureus and MRSA. The study showed the Aspergillus fumigatus Gliotoxin was effective against S. aureus and MRSA carrier in diabetics patients type-2 with foot ulcer, for S. aureus inhibition diameter was (20.50, 16.40, 12.20) mm for different concentrations of Gliotoxin, to MRSA was (8.25, 6.1, 4.20) mm. Its antibacterial effect was directly proportional with its concentration According to the values of MIC & MBC, the results revealed that the Gliotoxin of Aspergillus fumigatus were more effective as antibacterial agent against S. aureus and MRSA. Increasing rate of S. aureus carrier in diabetic patient's type-2 which lead to a significantly increased risk of bacterial infections. Gliotoxin was effective as antibacterial agent against S. aureus in type-2 diabetes . Keywords: Diabetes type-1, diabetes type-2, S. aureus nasal carriage, Aspergillus fumigatus, Gliotoxin (GT).

Diabetes type-1diabetes type-2S. aureus nasal carriageAspergillus fumigatusGliotoxin (GT).
30,809 views
9,251 downloads
DOI:
10.46624/bjmhr.2018.v5.i08.001

Contributors:

 Burooj M. Razooqi Al-aajem
,
 Adawia F. Abaas
,
 Anaam . F
,
 Eptissam Y. Pirko
Research PaperID: BJMHR0508002

The Molecular Classification of Women’s Breast Cancer by immunohistochemical, experience of Sidi Bel Abbes, Algeria.

Nawel AGHER, Nawel Agher, Abdenacer Tou

Breast cancer is the first cancer of women in Algeria but it remains a poorly known disease. Breast cancer is a heterogeneous disease from the clinical, histopathological and biological point of view with different prognoses and responses to different therapies. Traditional classifications including histological assessment and clinical staging are used to guide patient management. However, these prognostic and predictive factors are relatively crude measures and many patients are overtreated or undertreated as a result. Therefore, we propose, similarly to many series in the literature with 237 cases of invasive breast carcinoma (IBC) diagnosed at the Department of Pathology, Hospital-University-Center, Sidi Bel Abbes, Algeria, to address the new molecular classification of breast cancer by a conventional immunohistochemical (IHC ) approach, validated as a replacement technique for microarray analysis, which allows an individualisation of treatment. Our study showed 63.4% luminal tumors A, 10.5% luminal tumors B, 13.6% HER2 phenotype tumors, 12.5% of triple negative tumors whose 84.3% of normal-breast-like, 15.7% of non-basal-like tumors.

Breast cancersmolecular classificationluminalimmunohistochemical.
30,830 views
9,242 downloads
DOI:
10.46624/bjmhr.2018.v5.i08.002

Contributors:

 Nawel AGHER
,
 Nawel Agher
,
 Abdenacer Tou
Research PaperID: BJMHR0508003

Estimation of HbA1c and Microalbuminuria among Type 2 Diabetic Mellitus Sudanese Patients

AbdElkarim A Abdrabo, Tahani . Elamin, Mohammed . Ahmed

Diabetes mellitus is the commonest metabolic disorder and has a high prevalence in Sudan. Diabetic nephropathy is characterized by proteinuria and is the leading cause of end stage renal disease. Microalbuminuria testing is sensitive test for diabetic nephropathy. The present study aimed to estimate of HbA1c and micro albumin among type 2 diabetic mellitus in Sudanese patients and to correlate with duration of disease and age. This study was a cross sectional study conducted at Gaber Abu Elezz Diabetes Center-Khartoum state- Sudan, during March and November 2015, A total of (75) patients diagnosed with type 2 diabetic mellitus were enrolled in this study, Patients with systemic diseases like cardiovascular diseases, cerebrovascular diseases and urinary tract infection or kidney disease were excluded from the study. The blood sample collected in EDTA containers to estimate HbA1c levels which was measured by using (i- CHROMA), random urine specimens were collected to estimating microalbumin level of all the individuals under study. The study revealed that microalbuminuria, HbA1c levels were significantly increased in comparison with the reference range, p. value (0.009, 0.000), respectively, as well positive correlation between microalbuminuria and HbA1c and duration of disease, r. values was (0.603, 0.436) and p. values was (0.000, 0.000), respectively. The study revealed a clear relationship significant elevations of HbA1c and urinary micro albumin levels which suggest that the monitoring of micro albuminuria levels at the early stages of type 2 diabetic mellitus Sudanese patients. Keywords: Microalbumoinuria, HbA1c, Diabetes, Sudan, Neelain

MicroalbumoinuriaHbA1cDiabetesSudanNeelain
31,066 views
9,367 downloads
DOI:
10.46624/bjmhr.2018.v5.i08.003

Contributors:

 AbdElkarim A Abdrabo
,
 Tahani . Elamin
,
 Mohammed . Ahmed

Related Issues

Volume 13, Issue 1

2026 • 2 articles

Volume 12, Issue 12

2025 • 2 articles

Volume 12, Issue 11

2025 • 2 articles

Volume 12, Issue 10

2025 • 2 articles